SCHEMBL8588407

SCHEMBL8588407

NCC(Cc1cccnc1)NCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CHRNA7 P36544 1/20 0.45
ECE1 P42892 2/20 0.43
CYP2A6 P11509 1/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
KEAP1 Q14145 1/20 0.42
ALDH1A1 P00352 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RECQL P46063 1/20 0.42
FDPS P14324 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8590752 0.89 TSHR (0.45) CYP1A2CYP2D6CHRNA7CYP3A4ALDH1A1
SCHEMBL8591111 0.89 GAA (0.47) CYP1A2CYP2D6CHRNA7CYP2A6CYP3A4
SCHEMBL8589194 0.85 GAA (0.48) CYP3A4CYP2C9CYP2C19ALDH1A1NPSR1
SCHEMBL8587396 0.85 FFAR2 (0.45) CYP1A2CYP2D6CHRNA7CYP3A4CYP2C19
SCHEMBL8589515 0.85 CYP2D6 (0.46) CYP1A2CYP2D6CHRNA7CYP2A6CYP3A4
SCHEMBL8587389 0.85 ALDH1A1 (0.43) CYP1A2CYP2D6CHRNA7CYP2A6CYP3A4
SCHEMBL8586519 0.84 LMNA (0.47) CYP1A2CYP2D6CYP3A4ALDH1A1LMNA
SCHEMBL8589108 0.84 CHRNA7 (0.42) LTA4HCYP1A2CYP2D6CHRNA7CYP2A6
SCHEMBL21835602 0.84 SIGMAR1 (0.55) CYP3A4
SCHEMBL170305 0.84 SIGMAR1 (0.55) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998052890-A1 3-ARYLPROPYLAMINO NEUROPEPTIDE Y RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1998-11-26 WO disclosed